In our study in AS patients, myostatin emerged as a significant predictor of ventricular fibrosis, independent of age, gender, BMI, diabetes mellitus, statin therapy, apoptosis, PLIN5, and ceramides, explaining approximately 40% of the variance. The gene discussed is MSTN; the disease is diabetes mellitus.